Glenmark Pharmaceuticals (GLENMARK): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs.

1 min read Glenmark Pharmaceuticals

Corp. Action

Corp. Action

The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting.

The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting.

The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting.

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#GLENMARK PHARMACEUTICALS LTD #GLENMARK #Corporate announcement

Track Indian stocks with ZTOX AI

View pricing

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Real-time Updates

Filings and alerts in WhatsApp or Telegram

Smart Filtering

Focus on news that matter most to you

Start on the free plan

Track 5 companies at no cost. Upgrade anytime.

Track up to 50 Compnies
Insider deals notifications
Volume breakout detection (Purly informational)
Start Free Now